Is There Any Hope for WELL Health Stock?

WELL Health (TSX:WELL) stock has seen its shares plunge after full-year earnings. Should investors write off the stock?

| More on:

WELL Health Technologies (TSX:WELL) disappointed investors last week as the company came out with earnings that fell below estimates. Despite reporting record revenue and adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA), shares fell by 11%.

Furthermore, the outlook didn’t look great for WELL Health stock either. So, after a rough year and the future uncertain, is there any hope for WELL Health stock? Today, we’ll look at some options management may consider.

Focus

One of the popular items on WELL Health stock’s agenda over the last few years has been acquisitions. The company has managed to expand so rapidly with record revenue because of these acquisitions. And now, management has stated it will focus more on organic growth.

That would hopefully mean focusing on its core competencies and areas of strength within the healthcare technology sector. Streamlining operations and focusing resources on key products or services where it has an advantage could improve profitability.

This could indeed create more focus on the products that have done well. So, to stay competitive, it might be prudent to put less cash towards acquisitions and more towards innovating and developing products that have done well.

Partnerships instead of acquisitions

Another option, rather than these expensive acquisitions, is to create partnerships and alliances. Granted, this is already something the company has done in the past. This would easily expand market reach, access new customer segments, and even enhance product offerings.

While this could mean collaborations with hospitals, clinics, and insurance providers, it could also mean partnerships with tech companies as well. So, that will be another area for easy and less costly expansion.

Furthermore, this would likely enhance the customer experience. By prioritizing what the customer wants and clients, this would lead to loyalty, which leads to recurring revenue.

Optimize

WELL Health stock has already stated that it’s now focusing on cost optimization and streamlining its business. Implementing these cost-saving initiatives and efficiency measures can reduce operating expenses without compromising product quality or customer service. 

  • We just revealed five stocks as “best buys” this month … join Stock Advisor Canada to find out if Enbridge made the list!

This might involve renegotiating contracts with suppliers, leveraging technology for automated tasks, or simply consolidating loans. However, it could also mean a corporate restructure should things really start to go downhill.

However, it might also mean identifying areas where the company can diversify its core offerings. These might be areas of the market that would make sense to have exposure to rather than jumping into artificial intelligence, for example. Instead, seeking opinions from its clients can help identify where needs might be met.

Bottom line

So, is WELL Health stock done and dusted? I definitely do not think so. In fact, this could be shifting it into the next phase of its existence — away from the crazy growth by acquisition model. Instead, it means creating a financially stable company that will have strong organic growth and the ability to acquire as needed. Should the stock do this, it wouldn’t be unheard of to see the current $4 share price double in the next year or so.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has positions in Well Health Technologies. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Tech Stocks

space ship model takes off
Dividend Stocks

2 Stocks I’d Avoid in 2025 (and 1 I’d Buy)

Two low-priced stocks are best avoided for now but a surging oil bellwether is a must-buy.

Read more »

Canada national flag waving in wind on clear day
Tech Stocks

Trump Trade: Canadian Stocks to Watch

With Trump returning to the presidency, there are some sectors that could boom in Canada, and others to watch. But…

Read more »

ways to boost income
Tech Stocks

2 Stocks to Help Turn $100,000 Into $1 Million

Do you want to turn $100,000 into $1 million quickly? Look for small- or mid-cap stocks that are scaling as…

Read more »

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »